Trinity Biotech (TRIB) Reports In-Line Q3 EPS
Get Alerts TRIB Hot Sheet
Join SI Premium – FREE
Trinity Biotech (NASDAQ: TRIB) reported Q3 EPS of $0.07, in-line with the analyst estimate of $0.07. Revenue for the quarter came in at $26.1 million versus the consensus estimate of $26.5 million.
For earnings history and earnings-related data on Trinity Biotech (TRIB) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- urban-gro Inc. (UGRO) Misses Q4 EPS by 22c, offers outlook
- Rex American Resources Corp. (REX) Tops Q4 EPS by 48c
- Koil Energy Solutions, Inc. (KLNG) Reports Q4 Loss of $0.07
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!